This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, B.
Right arrow Articles by Kabilan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, B.
Right arrow Articles by Kabilan, L.

 Previous Article

Journal of Clinical Microbiology, May 2004, p. 2357-2358, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2357-2358.2004

LETTER TO THE EDITOR

Virological Interpretations of Dengue Disease Spectrum in Infants in Chennai, Tamil Nadu, India, Need Reevaluation


arrow
LETTER
 
We read with interest the study of Kabilan et al. (2) regarding the dengue disease spectrum in infants in Chennai, Tamil Nadu, India. However, certain points in this study regarding the virological investigations and their interpretations are not clear. As specified in the paper, the authors used dengue-specific immunoglobulin M (IgM) and IgG microenzyme-linked immunosorbent assay (microELISA) reagents for the detection of the respective antibodies. As a considerable number of cross-reactions occur between members of the flavivirus group, i.e., those causing dengue, Japanese encephalitis, and West Nile viral infections (1), it is worthwhile to look for specific IgM antibody against dengue viruses by the µ-capture technique. We have been working in the field of flaviviruses for the last decade (4, 5) and are using Pan-Bio µ-capture IgM microELISA reagents for the diagnosis of suspected dengue cases. In our experience, the µ-capture technique has been found to be better (94.7% sensitivity and 98.9% specificity, according to the manufacturer) than the non-µ-capture microELISA system so far as diagnosis of dengue virus infection is concerned. Hence, it would have been more useful if the authors had used the µ-capture technique for the serological confirmation of dengue virus infection in their study.

As is evident from Table 2 in the original study (2), two cases of dengue shock syndrome were diagnosed as acute dengue virus infections based upon the dengue virus IgG antibody only. In areas where dengue is endemic, it appears to be difficult even among infants to exclude the presence of either passively transferred maternal IgG antibodies or IgG antibodies acquired due to past exposure in the form of clinical or subclinical infection. The first problem would be easily eliminated by determining the absence of dengue virus IgG antibodies in the maternal serum. Otherwise, the role of dengue virus IgG antibody in the diagnosis of acute infection lies with either the demonstration of seroconversion or a significant rise in antibody titers in follow-up samples (1).

Since Kabilan et al. reported that the epidemic was due to dengue virus serotype 4, we would like to clarify that cross-reactions between flaviviruses as well as between dengue virus serotypes have been observed. It is difficult to type dengue viruses serologically by using the cross-reactive antigens that are available in many microELISA kits; i.e., the Pan-Bio dengue IgM kit utilizes dengue virus serotype 2 as the coating antigen, which cross-reacts with other dengue virus serotypes (serotypes 1, 3, and 4), whereas the Pan-Bio µ-capture IgM microELISA kit utilizes a pool of dengue virus serotypes 1 to 4 as the source of common dengue virus antigen. None of the kits mentioned above have the ability to differentiate between the serotypes unless serotype-specific antigenic determinants of dengue viruses are used individually in separate kits. At best, this type of kit can be used only for diagnosing acute dengue virus infection, not for serotyping. Conventionally, serotyping is done by neutralization, immunofluorescence tests using type-specific antisera (1), or reverse transcriptase PCR using type-specific primers (3).

Hence, it would be worthwhile to know the type of antigens the authors used to determine the infection to be caused by dengue virus serotype 4. This information would be of much use to the researchers working in similar fields.


arrow
REFERENCES
 
    1
  1. Calisher, C. H., B. J. Beaty, and L. J. Chandler. 1999. Arboviruses, p. 305-332. In E. H. Lennette and T. F. Smith (ed.), Laboratory diagnosis of viral infections. Marcel Dekker Inc., New York, N.Y.
  2. 2
  3. Kabilan, L., S. Balasubramanian, S. M. Keshava, V. Thenmozhi, G. Sekar, S. C. Tewari, N. Arunachalam, R. Rajendran, and K. Satyanarayana. 2003. Dengue disease spectrum among infants in the 2001 dengue epidemic in Chennai, Tamil Nadu, India. J. Clin. Microbiol. 41:3919-3921.[Abstract/Free Full Text]
  4. 3
  5. Morita, K., M. Tanaka, and A. Igarashi. 1991. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J. Clin. Microbiol. 29:2107-2110.[Abstract/Free Full Text]
  6. 4
  7. Ratho, R. K., and S. R. Prasad. 1998. A serological study of flaviviral infections in Chandigarh. Indian J. Virol. 14:143-146.
  8. 5
  9. Ratho, R. K., S. Sethi, and S. R. Prasad. 1999. Prevalence of Japanese encephalitis and West Nile viral infections in pig population in and around Chandigarh. J. Commun. Dis. 31:113-116.[Medline]
Baijayantimala Mishra
R. K. Ratho

Department of Virology, Postgraduate Institute of Medical Education, Chandigarh, India


Author's Reply


arrow
LETTER 
 
It is a great pleasure for me to respond to Dr. Mishra's letter and to clarify the following points. First, in our study we used the µ-capture technique for serological confirmation. Second, what we said in the paper was that while dengue virus-specific IgM responses were predominant in most (23 of 24) dengue fever (DF) cases, the five infants with severe forms of dengue disease elicited IgG responses with or without IgM responses (Table 2 of reference 1), suggesting that the DF and dengue hemorrhagic fever-dengue shock syndrome cases were due to primary and secondary dengue virus infections, respectively. The cases were categorized by clinical and serological criteria. We fully agree with Dr. Mishra's point of view as to the role of dengue virus-specific IgG antibody in the diagnosis of acute infection, which depends on demonstration of either seroconversion or a significant rise in antibodies in the paired sera. Collection of paired sera was not possible for us because of practical difficulties. Third, we are aware of the cross-reactions of antiflavivirus antibodies and among the dengue virus serotype-specific antigens as well. In our study, we used dengue virus serotype-specific antigens supplied by the Centers for Disease Control and Prevention, Fort Collins, Colo. In the absence of an immune response to the particular monovalent antigen, it has been claimed that the highest IgM responses were against the infecting dengue virus serotype in most of the individuals confirmed to have dengue virus infections (2). Following the report of our study (1), we isolated dengue virus of serotype 4 from a patient's serum by using an insect bioassay system (i.e., an immunofluorescence assay using the larvae of Toxorhynchites splendens).


arrow
REFERENCES 
 
    1
  1. Kabilan, L., S. Balasubramanian, S. M. Keshava, V. Thenmozhi, G. Sekar, S. C. Tewari, N. Arunachalam, R. Rajendran, and K. Satyanarayana. 2003. Dengue disease spectrum among infants in the 2001 dengue epidemic in Chennai, Tamil Nadu, India. J. Clin. Microbiol. 41:3919-3921.
  2. 2
  3. Nawa, M., K.-I. Yamada, T. Takasaki, T. Akatsuka, and I. Kurane. 2000. Se-rotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 7:774-777.[Abstract/Free Full Text]
Lalitha Kabilan*
CRME, 4, Sarojini St. Chinna Chokikulam Madurai-2, India

* E-mail: dicrme{at}sify.com


Journal of Clinical Microbiology, May 2004, p. 2357-2358, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2357-2358.2004




This article has been cited by other articles:

  • Malavige, G N, Ranatunga, P K, Velathanthiri, V G N S, Fernando, S, Karunatilaka, D H, Aaskov, J, Seneviratne, S L (2006). Patterns of disease in Sri Lankan dengue patients. Arch. Dis. Child. 91: 396-400 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, B.
Right arrow Articles by Kabilan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, B.
Right arrow Articles by Kabilan, L.